Accendra HealthvsAmgen

ACH and AMGN stock compared: price, dividend, valuation and results, from SEC filings.

ACH

Accendra Health, Inc.

$0.09

Value $6.6M

-30.77%
ACH's page

AMGN

Amgen Inc.

$462.32

Value $249B

-0.72%
AMGN's page

Accendra Health (ACH) has a market value of $6.6M and Amgen (AMGN) $249B. Over the last year, with dividends, ACH moved -96.8% and AMGN +41.1%. Dividend yield: ACH none, AMGN 2.15%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ACH$6.6M

    AMGN$249B

    AMGN is 38,045 times ACH

  • Revenue, 12 months

    ACH$2.6B

    AMGN$38.9B

    AMGN is 15 times ACH

  • Net income, 12 months

    ACH-$172M

    AMGN$9.4B

  • Operating margin

    ACH0.2%

    AMGN32.4%

    32.2 points apart

  • ROIC

    ACH0.2%

    AMGN16.2%

    16.0 points apart

  • P/E

    ACH–

    AMGN26.5

  • Dividend yield

    ACH0.0%

    AMGN2.2%

    2.2 points apart

  • 5-year return

    ACH-99.8%

    AMGN+158.3%

    258.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ACH-99.8%

AMGN+158.3%

010020020222023202420252026
Returns by period
PeriodACHWith dividendsAMGNWith dividends
1 year since November 14, 2025-96.8%Price -96.8%+41.1%Price +37.3%
3 years since November 16, 2023-99.5%-82.9% a yearPrice -99.5%+86.6%+23.1% a yearPrice +71.9%
5 years since November 15, 2021-99.8%-70.9% a yearPrice -99.8%+158.3%+20.9% a yearPrice +122.9%
10 years since November 16, 2016-99.7%-44.1% a yearPrice -99.7%+320.0%+15.4% a yearPrice +214.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ACHAccendra HealthAMGNAmgen

Valuation

ACHAMGN
Valuation
Price$0.09$462.32
Market value$6.6M$249B
Enterprise value (EV)$1.7B$290B
P/E–26.5
P/E, 5-year median–23.0
P/B–17.4
EV/EBIT411.323.0
Free cash flow yield–3.8%

Results and growth

ACHAMGN
Results and growth
Revenue, 12 months$2.6B$38.9B
Net income, 12 months-$172M$9.4B
Free cash flow, 12 months-$199M$9.6B
Earnings per share, 12 months-$2.25$17.25
Revenue growth, year on year3.1%10.0%
Revenue growth a year, past-20.1%over 5 years+7.6%over 5 years
EPS growth a year, past–+2.9%over 5 years

Margins and returns on capital

ACHAMGN
Margins and returns on capital
Gross margin44.1%70.9%
Operating margin0.2%32.4%
Net margin-6.7%24.1%
ROIC0.2%16.2%
ROE–87.8%

Balance sheet

ACHAMGN
Balance sheet
Cash$27M$13.2B
Total debt$1.9B$54.0B
Net debt / EBITDA7.92.3
Interest cover0.0×4.8×

Dividends and buybacks

ACHAMGN
Dividends and buybacks
Dividend yield–2.2%
Dividend per share, 12 months–$9.94
Dividend growth a year, past–+8.1%over 5 years
Buyback yield155.4%–
Shareholder yield155.4%2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ACH or AMGN

Didn't find what you were looking for?

Ask us
Which is bigger, Accendra Health or Amgen?

By market value, Amgen ($249B) is about 38,045.4 times Accendra Health ($6.6M), at today's prices.

How did ACH and AMGN stock do over the last 10 years?

Since November 16, 2016, ACH's price moved -99.7% and AMGN's +214.0%. With dividends: ACH -99.7% (-44.1% a year), AMGN +320.0% (+15.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ACH or AMGN?

The dividend yield at today's price is none for Accendra Health and 2.15% for Amgen. Over the last twelve months they paid – and $9.94 per share.

Which has the higher profit margins, Accendra Health or Amgen?

Over the last twelve months, the net margin was -6.7% for Accendra Health and 24.1% for Amgen, and the operating margin 0.2% and 32.4%. Revenue was $2.6B and $38.9B.

Which is the better investment, Accendra Health or Amgen?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.